openPR Logo
Press release

Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing technique the cancer RNA expression market is segmented as: Targeted RNA Sequencing Small RNA and miRNA sequencing Transcriptome Sequencing PCR Sequencing)

06-04-2019 12:09 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Cancer RNA Expression Market to Reap Excessive Revenues

Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may also vary person to person. The exhaustive study of changes in gene expression and mutation patterns in different cancer type is one of the most studied topic for developing novel cure for cancer. Cancer RNA expression plays an important role in the studying mutation patterns and if understood wholly for particular person it may help in speedy recovery and cure. In recent days the gene therapy for cancer treatment is mainly driven by the cancer RNA expression and DNA expression. Cancer RNA expression plays an important role in the PCR sequencing enabling enhanced understanding of different mutations in cancerous cells.

Cancer RNA Expression Market: Drivers and Restraints

Increasing prevalence of the cancer is major driver in the growth of cancer RNA expression market. Comparatively early diagnosis of the cancer further enables to borrow some extra time for the additional therapies for better treatment outcome along with choice of treatments such as chemotherapy, radiotherapy and surgical intervention driving the growth of cancer RNA expression market. The large number of studies going on to study the cancer RNA expression further expected to strengthen the pipeline product availability driving the growth of cancer RNA expression market. Chemotherapy and radiotherapy helps to kill the cancerous cells and in that process non-cancerous cells are also killed whereas in cancer RNA expression, it is possible to target only mutated cells which in turn minimizes the side effects of cancer treatment significantly. The conditions such as anemia, neutropenia and thrombocytopenia are common side effects in the cancer patients undergoing chemotherapy which further increases the cost of treatment significantly as well as patient sustainability but in case of cancer RNA expression the targeted gene therapy allows healthcare professionals to minimize the side effects. Whereas, low availability of marketed products may hamper the growth of the cancer RNA expression market.

Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=3149

Cancer RNA Expression Market: Segmentation

The global cancer RNA expression market is segmented based on the by sequencing technique, end user and region

By sequencing technique the cancer RNA expression market is segmented as:

Targeted RNA Sequencing
Small RNA and miRNA sequencing
Transcriptome Sequencing
PCR Sequencing
By end user the cancer RNA expression market is segmented as:

Diagnostic Laboratories
Hospitals
Specialty Clinics
Academic Research Institutes
Cancer RNA Expression Market: Overview

The significant amount of research and development going on in the cancer RNA expression market is expected to be the major growth driving factor. By the sequencing technique the cancer RNA expression market is expected to be dominated by small RNA and miRNA sequencing technique due to fast evolving applications of the technique. By end user the cancer RNA expression market is expected to be dominated by the hospitals due to high number of patient footfall for the diagnosis as well as treatment. The manufacturers in the cancer RNA expression market are focusing on the developing novel formulation and technique for the effective cancer treatment.

Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=3149

Cancer RNA Expression Market: Regional Outlook

The global cancer RNA expression market is expected to be dominated by the North America due to comparatively superior availability of the cancer RNA expression sequencing techniques and cancer mutation specific approach of treatment. Europe is expected to be the second most lucrative cancer RNA expression market due to better reimbursement scenario and early diagnosis of the cancer. The Asia-Pacific is emerging cancer RNA expression market due to rapidly evolving healthcare infrastructure. Latin America is expected to witness steady growth to gradually increasing product penetration in the cancer RNA expression market. Middle East and Africa is the least lucrative cancer RNA expression market due to low rate of early diagnosis and lack of novel treatment options in most of the region.

Cancer RNA Expression Market: Key Players

The key market players operating in the cancer RNA expression market are: Thermo Fisher Scientific, Illumina Inc., Pacific Biosciences of California Inc., PerkinElmer Inc., QIAGEN N. V., GATC Biotech AG, Macrogen, Inc., Oxford Nanopore Technologies Ltd., Roche Holding AG, Eurofins Scientific among others.

The research report presents a comprehensive assessment of the Cancer RNA Expression market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to Cancer RNA Expression market segments such as geographies, application, and industry.

The report covers exhaust analysis on:

Cancer RNA Expression Market Segments
Cancer RNA Expression Market Dynamics
Cancer RNA Expression Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Indication
Value Chain
Regional analysis includes:

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain)
Eastern Europe (Poland, Russia)
Asia-Pacific excluding Japan (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC Countries, South Africa, Northern Africa)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current, and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Report Analysis@ https://www.factmr.com/report/3149/cancer-rna-expression-market

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing technique the cancer RNA expression market is segmented as: Targeted RNA Sequencing Small RNA and miRNA sequencing Transcriptome Sequencing PCR Sequencing) here

News-ID: 1763813 • Views:

More Releases from Fact.MR

Craft Spirit Market Anticipates $ 59.47 Billion Valuation by 2034, Driven by 29% CAGR
05-21-2024 | Food & Beverage
Fact.MR
Craft Spirit Market Anticipates $ 59.47 Billion Valuation by 2034, Driven by 29% …
According to the most recent market analysis conducted by knowledgeable analysts at Fact.MR, the size of the worldwide craft spirit market is estimated to be worth US$ 20.5 billion in 2023 and is expected to grow at a CAGR of 29% to reach a valuation of US$ 230 billion by the end of 2033. Craft spirits are growing in popularity because of their exceptional flavor, quality, and distinctiveness. The craft spirits
Bank Kiosk Market Forecasted to Expand Rapidly, Projecting US$ 80 Billion Value by 2033, with 15% CAGR
Bank Kiosk Market Forecasted to Expand Rapidly, Projecting US$ 80 Billion Value …
A recent analysis by knowledgeable experts at Fact.MR values the worldwide bank kiosk market at US$ 18.5 billion in 2023 and projects it will grow at a CAGR of 15% to reach US$ 80 billion by the end of 2033. An automated self-service device called a bank kiosk offers customers a range of banking services without the need for human support. A vital component of the contemporary banking infrastructure, bank kiosks
Smart Badges Market To Witness Exponential Growth, Expected to Hit US$ 50 Billion by 2033 at 9% CAGR
Smart Badges Market To Witness Exponential Growth, Expected to Hit US$ 50 Billio …
The smart badge market is expected to grow at a remarkable compound annual growth rate (CAGR) of 9% from 2023 to 2033, from its estimated valuation of US$ 21 billion in 2023 to US$ 50 billion by 2033. An electrical gadget with an embedded memory or microcontroller in the shape of a touch pad is called a smart badge. It establishes a connection with a reader by short-range wireless connectivity or
Pod Vapes Market Is Forecasted To Increase At A CAGR Of 12.5% By 2033: Fact.MR Report
Pod Vapes Market Is Forecasted To Increase At A CAGR Of 12.5% By 2033: Fact.MR R …
The global pod vape market, valued at USD 2.52 billion in 2023, is projected to grow significantly, reaching USD 8.18 billion by 2033. This expansion represents a compound annual growth rate (CAGR) of 12.5% over the decade. The Pod Vape Industry sales study offers a comprehensive analysis on diverse features including production capacities, Pod Vape demand, product developments, sales revenue generation and Pod Vape market outlook across the globe. market research report

All 5 Releases


More Releases for RNA

Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand. Browse 156 Market Data Tables and 112 Figures spread through 175
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited. Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year. Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018! Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion. One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and
Special student rate for RNA Nanotechnology conference
Fusion Conferences and the Chairs of RNA Nanotechnology have introduced a Special Student Rate for their conference on 01-04 August 2016. The conference, to be held at Wokefield Park in Berkshire, UK, sold out earlier this month with registrations being closed off to the public, but Fusion have opened up some spaces to allow students to enjoy the conference at a discounted rate. Dr. Peixuan Guo of Ohio State University and one